Pieter Rottiers

Pieter Rottiers

Pieter Rottiers

CEO - Precigen ActoBio

Dr. Pieter Rottiers serves as CEO of Precigen ActoBio, an innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents and a wholly-owned subsidiary of Precigen, Inc. Dr. Rottiers is an entrepreneurial leader with extensive experience in drug discovery and development using the ActoBiotics® platform, including more than 17 years of leadership and managerial experience in the biopharma industry. Dr. Rottiers has held several R&D and executive management roles at ActoGeniX and Intrexon Corporation, and progressed four products from discovery research into clinical trials. Dr. Rottiers received his PhD in Biotechnology from the University of Ghent, Belgium, and was for several years principle investigator at the Flanders Institute for Biotechnology.

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners